Literature DB >> 29230642

A case of a protruded lesion formed by a poorly differentiated intramucosal adenocarcinoma of the stomach: an immunohistochemical analysis.

Keiichiro Nakajo1, Yasuhiro Oono2, Takeshi Kuwata3, Tomonori Yano1.   

Abstract

A 70-year-old woman underwent upper gastrointestinal endoscopy and was found to have a 25-mm protruded lesion in the gastric body. A biopsy revealed malignant cells. Endoscopic submucosal dissection was performed. Histopathologically, the tumor was mainly composed of poorly differentiated adenocarcinoma (PDA), while moderately differentiated adenocarcinoma was observed on its superficial layer. The tumor was located within the mucosal layer. PDAs rarely form a protruded lesion. Here, the presence of a moderately differentiated adenocarcinoma element in the superficial layer of the tumor might have protected the tumor cells from erosion, and solid proliferation of the PDA also contributed to its outward growth.

Entities:  

Keywords:  Early gastric cancer; Endoscopic submucosal dissection; Poorly differentiated adenocarcinoma; Protruded type

Mesh:

Year:  2017        PMID: 29230642     DOI: 10.1007/s12328-017-0804-6

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  3 in total

Review 1.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

2.  Gastric adenocarcinoma of the fundic gland type (chief cell predominant type).

Authors:  Hiroya Ueyama; Kenshi Matsumoto; Akihito Nagahara; Takuo Hayashi; Takashi Yao; Sumio Watanabe
Journal:  Endoscopy       Date:  2013-12-11       Impact factor: 10.093

3.  Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma.

Authors:  Hiroya Ueyama; Takashi Yao; Yutaka Nakashima; Katsuya Hirakawa; Yumi Oshiro; Minako Hirahashi; Akinori Iwashita; Sumio Watanabe
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.